Amorfix Life Sciences Ltd. Announces 2008 Year End Results
TORONTO, June 13 /CNW/ - Amorfix Life Sciences, a company focused on
treatments and diagnostics for brain wasting diseases, today announced its
operational and financial results for the year ended March 31, 2008, as well
as financial results for the fourth quarter.